In 2018, the FDA approved Epidiolex — a purified CBD oral solution — making it the first cannabis-derived pharmaceutical ever approved in the United States. This was not a minor footnote. It changed the scientific and regulatory conversation around CBD permanently, and understanding what Epidiolex is explains a great deal about why CBD is taken seriously as a medicine.
What Is Epidiolex?
Epidiolex is a pharmaceutical-grade CBD oral solution manufactured by GW Pharmaceuticals (now Jazz Pharmaceuticals). It contains purified cannabidiol derived from cannabis plants, formulated at a precise concentration for medical use. It is prescribed by neurologists for two rare and severe forms of childhood epilepsy:
- Dravet syndrome — a severe genetic epilepsy that begins in the first year of life, causes frequent prolonged seizures, and is notoriously resistant to standard antiepileptic drugs
- Lennox-Gastaut syndrome — another severe form of childhood epilepsy characterized by multiple seizure types and intellectual disability
- Tuberous sclerosis complex — a genetic disorder causing benign tumours to grow in the brain and other organs, often causing epilepsy (added indication in 2020)
The Clinical Evidence That Got It Approved
The FDA does not approve drugs on anecdotes. Epidiolex’s approval was based on three large randomized controlled trials — the gold standard of medical evidence:
- In the Dravet syndrome trial published in the New England Journal of Medicine (2017), CBD reduced seizure frequency by a median of 38.9% compared to 13.3% for placebo — a clinically and statistically significant difference
- In two Lennox-Gastaut trials published in The Lancet Neurology, CBD reduced drop seizure frequency by 41.9% and 37.2% respectively, compared to 8.4% and 17.2% for placebo
These are not small effects. For children with conditions where seizures can occur dozens of times per day, a 38–42% reduction is life-changing.
Why Epidiolex Matters for CBD Broadly
Epidiolex proves several things that were previously debated:
- CBD is pharmacologically active — it produces measurable, reproducible medical effects in controlled trials
- CBD is safe at high doses long-term — Epidiolex is dosed at 10–20 mg/kg/day in children, far exceeding typical wellness doses, without addiction or serious safety signals
- CBD works through the brain — it crosses the blood-brain barrier and exerts neurological effects, validating its use for anxiety, PTSD, and sleep conditions
When you read about CBD’s “scientific credibility,” Epidiolex is the foundation of that claim. No other cannabinoid (except THC in a few narrow contexts) has matched this level of regulatory validation.
Is Epidiolex the Same as Over-the-Counter CBD?
No — but the active molecule is the same. Epidiolex is pharmaceutical-grade, precisely dosed, and administered under medical supervision. OTC CBD products vary in quality, purity, and actual CBD content. The FDA approval of Epidiolex does not mean all CBD products are medically approved for any use — it means CBD as a molecule has been proven to work for specific conditions at specific doses in controlled settings.
For wellness use, quality CBD products with verified COAs provide the same molecule — the mechanism is there, even if the clinical validation is specific to epilepsy. See our guide to reading a CBD COA to verify what is actually in any product you buy.
Frequently Asked Questions
What is Epidiolex used for?
Epidiolex is the first FDA-approved cannabis-derived drug — prescribed for Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. All are severe forms of epilepsy resistant to standard treatment.
Does CBD really help epilepsy?
Yes — this is the best-proven use of CBD. Trials in the New England Journal of Medicine and The Lancet Neurology showed 38–42% seizure reduction in children with Dravet and Lennox-Gastaut syndromes versus placebo.
Can I use regular CBD instead of Epidiolex?
No. Epidiolex is a precisely dosed pharmaceutical used under medical supervision. Never substitute OTC CBD for prescribed epilepsy medication without neurologist guidance.
